Amlodipine and Olmesartan Medoxomil Tablets
Ascend Laboratories is recalling Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg, due to failed dissolution specifications.
Contact your healthcare provider or pharmacist to discuss alternative treatment options. Do not stop taking your medication without consulting a medical professional.
Why it was recalled
Ascend Laboratories is recalling Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg, due to failed dissolution specifications where the Olmesartan Medoxomil content is below the required levels. This recall affects the 30-count bottle presentation.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Amlodipine and Olmesartan Medoxomil Tablets
- Lot code
- 24123460, 2027
- Strength
- 5 mg
- UPC
- 24123460
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Other recent recalls from Ascend Laboratories, LLC
Editorial summary by Recall Canary · summary updated 2026-06-03 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification